141 related articles for article (PubMed ID: 2086740)
1. Factor analysis of the immunophenotypes of astrocytomas and malignant gliomas: correlations with tumor grade and patient survival.
Jennings MT; Asadourian LL; Jennings VD; Shapiro JR; Thaler HT
J Neurooncol; 1990 Dec; 9(3):265-73. PubMed ID: 2086740
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic differences between normal glia, astrocytomas and malignant gliomas: correlations with karyotype, natural history and survival.
Jennings MT; Ebrahim SA; Thaler HT; Jennings VD; Asadourian LL; Shapiro JR
J Neuroimmunol; 1989 Nov; 25(1):7-28. PubMed ID: 2685039
[TBL] [Abstract][Full Text] [Related]
3. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
4. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
Deckert M; Reifenberger G; Wechsler W
J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
[TBL] [Abstract][Full Text] [Related]
5. Autologous serologic responses in glioma patients. Correlation with tumor grade and survival.
Kornblith PL; Coakham HB; Pollock LA; Wood WC; Green SB; Smith BH
Cancer; 1983 Dec; 52(12):2230-5. PubMed ID: 6640493
[TBL] [Abstract][Full Text] [Related]
6. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens.
de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S
Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398
[TBL] [Abstract][Full Text] [Related]
7. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis.
Higuchi M; Ohnishi T; Arita N; Hiraga S; Hayakawa T
Acta Neuropathol; 1993; 85(5):481-7. PubMed ID: 7684178
[TBL] [Abstract][Full Text] [Related]
8. Patterns of antigenic expression of human glioma cells.
McKeever PE; Davenport RD; Shakui P
Crit Rev Neurobiol; 1991; 6(2):119-47. PubMed ID: 1934088
[TBL] [Abstract][Full Text] [Related]
9. Antigenic staining patterns of human glioma cultures: primary cultures, long-term cultures and cell lines.
Westphal M; Nausch H; Herrmann HD
J Neurocytol; 1990 Aug; 19(4):466-77. PubMed ID: 2243242
[TBL] [Abstract][Full Text] [Related]
10. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
Patt S; Giraldo M; Martin H
Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
[TBL] [Abstract][Full Text] [Related]
11. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
12. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous demonstration of glia- and glioma-associated antigens in human astrocytomas.
Bilzer T; Martin B; Stavrou D; Keiditsch E
Int J Cancer Suppl; 1988; 2():41-4. PubMed ID: 3162445
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas.
Schmits R; Cochlovius B; Treitz G; Regitz E; Ketter R; Preuss KD; Romeike BF; Pfreundschuh M
Int J Cancer; 2002 Mar; 98(1):73-7. PubMed ID: 11857388
[TBL] [Abstract][Full Text] [Related]
15. Five novel cell surface antigens of CNS neoplasms.
Jennings MT; Jennings VD; Asadourian LL; Rosenblum M; Albino AP; Cairncross JG; Old LJ
J Neurol Sci; 1989 Jan; 89(1):63-78. PubMed ID: 2926443
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets.
Rettig WJ; Chesa PG; Beresford HR; Feickert HJ; Jennings MT; Cohen J; Oettgen HF; Old LJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6406-12. PubMed ID: 2877731
[TBL] [Abstract][Full Text] [Related]
17. The expression of the epitope H recognized by the monoclonal antibody H is higher in astrocytomas compared to anaplastic astrocytomas and glioblastomas.
Arvanitis DL; Arvanitis LD; Panourias IG; Kitsoulis P; Kanavaros P
Histol Histopathol; 2005 Oct; 20(4):1057-63. PubMed ID: 16136487
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres].
Korshunov AG; Sycheva RV
Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
